Please wait while we open this resource.
K
Clinical notes
pharmacology of Diabetes mellitus drugs
Isaac Magulu Kimbowa
PPTX103 pages2.3 MB
The document defines diabetes mellitus and distinguishes between type 1 and type 2 disease, describing their pathophysiology and clinical manifestations. It details the mechanisms, efficacy, and adverse effects of sulfonylureas, as well as newer drug classes such as GLP‑1 agonists and DPP‑4 inhibitors. Diagnostic criteria, including glucose tolerance testing, are also presented. Learning objectives guide the reader to understand key terms, disease mechanisms, and pharmacologic differences among oral and parenteral agents.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
DIABETES MELLITUS
Same clinical topic · Endocrinology
Williams Textbook of Endocrinology (2019, Elsevier)
Same clinical topic · Endocrinology
Oxford Desk Reference Endocrinology 1st edition
Same clinical topic · Endocrinology
Practical Clinical Endocrinology Peter Igaz-2021
Same clinical topic · Endocrinology
Endocrine Secrets 8th edition 2026
Same clinical topic · Endocrinology
PHARMACOLOGY OF DIABETES MELLITUS
Same clinical topic · Endocrinology
THE GLUCOCORTICOID TAPER: A PRIMER FOR THE CLINICIANS
Same clinical topic · Endocrinology
ENDOCRINE MKSAP 19 BOARDBASICS
Same clinical topic · Endocrinology
THE GLUCOCORTICOID TAPER: A PRIMER FOR THE CLINICIANS
Same clinical topic · Endocrinology